Federation des caisses Desjardins du Quebec’s VanEck Pharmaceutical ETF PPH Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$72.2K	Hold	695	–	–	﹤0.01%	1772
2025 Q4	$71.7K	Buy	695 +75	+12%	+$7.3K	﹤0.01%	1735
2025 Q3	$56K	Buy	620 +220	+55%	+$19.3K	﹤0.01%	1783
2025 Q2	$35.2K	Hold	400	–	–	﹤0.01%	1641
2025 Q1	$36.5K	Sell	400 -131,697	-100%	-$11.9M	﹤0.01%	1547
2024 Q4	$11.4M	Buy	132,097 +131,697	+32,924%	+$11.9M	0.06%	209
2024 Q3	$38K	Hold	400	–	–	﹤0.01%	1473
2024 Q2	$36.6K	Hold	400	–	–	﹤0.01%	1462
2024 Q1	$36.3K	Hold	400	–	–	﹤0.01%	1493
2023 Q4	$32.5K	Hold	400	–	–	﹤0.01%	1443
2023 Q3	$31.9K	Hold	400	–	–	﹤0.01%	1438
2023 Q2	$31.5K	Hold	400	–	–	﹤0.01%	1461
2023 Q1	$31.1K	Hold	400	–	–	﹤0.01%	1453
2022 Q4	$31.1K	Hold	400	–	–	﹤0.01%	1573
2022 Q3	$26.9K	Hold	400	–	–	﹤0.01%	1667
2022 Q2	$30.7K	Hold	400	–	–	﹤0.01%	1641
2022 Q1	$31.9K	Hold	400	–	–	﹤0.01%	1707
2021 Q4	$30.8K	Hold	400	–	–	﹤0.01%	1719
2021 Q3	$29.1K	Hold	400	–	–	﹤0.01%	1744
2021 Q2	$29.2K	Hold	400	–	–	﹤0.01%	1752
2021 Q1	$27.6K	Hold	400	–	–	﹤0.01%	1724
2020 Q4	$26.6K	Hold	400	–	–	﹤0.01%	1668
2020 Q3	$24.9K	Sell	400 -200	-33%	-$12.6K	﹤0.01%	1433
2020 Q2	$37.4K	Hold	600	–	–	﹤0.01%	1288
2020 Q1	$32.6K	Hold	600	–	–	﹤0.01%	1379
2019 Q4	$38.5K	Hold	600	–	–	﹤0.01%	1584
2019 Q3	$34.2K	Hold	600	–	–	﹤0.01%	1559
2019 Q2	$35.2K	Hold	600	–	–	﹤0.01%	1569
2019 Q1	$36.4K	Hold	600	–	–	﹤0.01%	1391
2018 Q4	$32.9K	Buy	600 +200	+50%	+$12.1K	﹤0.01%	1384
2018 Q3	$25.7K	Sell	400 -2,000	-83%	-$125K	﹤0.01%	1498
2018 Q2	$142K	Hold	2,400	–	–	﹤0.01%	1111
2018 Q1	$136K	Hold	2,400	–	–	﹤0.01%	1109
2017 Q4	$142K	Hold	2,400	–	–	﹤0.01%	1105
2017 Q3	$139K	Hold	2,400	–	–	﹤0.01%	1084
2017 Q2	$142K	Sell	2,400 -1,000	-29%	-$56.6K	﹤0.01%	1104
2017 Q1	$187K	Buy	+3,400	New	+$184K	﹤0.01%	919

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's PPH Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its VanEck Pharmaceutical ETF (PPH) position steady in Q1 2026 at 695 shares worth $72.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1772.

Federation des caisses Desjardins du Quebec first reported a position in PPH in Q1 2017 and has held it in 37 quarters since. The position peaked at $11.4M in Q4 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

Federation des caisses Desjardins du Quebec held 695 shares of VanEck Pharmaceutical ETF worth $72.2K as of Q1 2026.
Federation des caisses Desjardins du Quebec left its VanEck Pharmaceutical ETF share count unchanged in Q1 2026.
VanEck Pharmaceutical ETF made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #1772 holding.
Federation des caisses Desjardins du Quebec first reported a position in VanEck Pharmaceutical ETF in Q1 2017 and has held it in 37 quarters since.
Federation des caisses Desjardins du Quebec's VanEck Pharmaceutical ETF position peaked at $11.4M in Q4 2024.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.